Richard J. Honeywell — Amsterdam UMC - Vrije Universiteit Amsterdam

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

58 Article
4 Meeting Abstract
2 Comment/Letter to the editor
1 Letter
More
- 1 Review article

11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy
Mammatas, L. H., Yaqub, M., Hendrikse, N. H., Hoekstra, O. S., Honeywell, R. J., Schuit, R. C., Meijerink, M., Schwarte, L. A., Peters, G. J., Verheul, H. M. W., Lammertsma, A. A. & Menke-van der Houven van Oordt, C. W., 1 Jul 2021, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 62, 7, p. 934-940 7 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: lessons from the CounterCovid - imatinib - study
Bartelink, I. H., Bet, P. M., Widmer, N., Guidi, M., Duijvelaar, E., Grob, B., Honeywell, R., Evelo, A., Tielbeek, I. P. E., Snape, S. D., Hamer, H., Decosterd, L. A., Bogaard, H. J., Aman, J. & Swart, E. L., 5 Oct 2021, In: CPT: Pharmacometrics and Systems Pharmacology.
Research output: Contribution to journal › Article › Academic › peer-review
The prognostic impact of circulating miRNAs in patients with advanced esophagogastric cancer during palliative chemotherapy
van Zweeden, A. A., Opperman, R. C. M., Honeywell, R. J., Peters, G. J., Verheul, H. M. W., van der Vliet, H. J. & Poel, D., 1 Jan 2021, In: Cancer Treatment and Research Communications. 27, 100371.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function
Van Der Steen, N., Keller, K., Dekker, H., Porcelli, L., Honeywell, R. J., Van Meerloo, J., Musters, R. J. P., Kathmann, I., Frampton, A. E., Liu, D. S. K., Ruijtenbeek, R., Rolfo, C., Pauwels, P., Giovannetti, E. & Peters, G. J., 1 Nov 2020, In: Journal of Cellular Physiology. 235, 11, p. 8085-8097 13 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Epithelial transfer of the tyrosine kinase inhibitors erlotinib, gefitinib, afatinib, crizotinib, sorafenib, sunitinib, and dasatinib: Implications for clinical resistance
Honeywell, R. J., Kathmann, I., Giovannetti, E., Tibaldi, C., Smit, E. F., Rovithi, M. N., Verheul, H. M. W. & Peters, G. J., 1 Nov 2020, In: Cancers. 12, 11, p. 1-18 18 p., 3322.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access